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ABSTRACT
A new design for a canine elbow joint replacement was manufactured and assembled.  The 
design incorporates a ceramic ball for articulation with radius and ulna components and a 
bioactive ceramic for tissue contact.  A variety of materials were considered, with zirconia-
toughened alumina selected as the wear surface, stainless steel as the structural backbone, 
and osteoceramic as the bioactive bone interface.  The ceramic components were 
manufactured by cold isostatic pressing the powders, firing the formed rods to an 
intermediate temperature for strength, and then machining them before a final sintering.  A 
modified osteoceramic bone cement with better flow characteristics was chosen instead of 
poly(methylmethacrylate) bone cement for fixation of the ulna component.   
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INTRODUCTION  
Elbow replacement surgeries are much less common than hip replacements and therefore 
have received less attention from researchers.  Two possible reasons for replacing an elbow 
joint are rheumatoid arthritis or posttraumatic arthritis, usually with significant bone loss [1].  
The most common practice for elbow replacement is to cement separate rods into the 
humerus and ulna and attach them through a hinge joint. 
Current elbow implants have improved the quality of life for many human patients; however, 
the five year survival rate for a common implant of this type (Coonrad-Morrey total elbow 
replacement) is only 72% [1].  Poly(methylmethacrylate) (PMMA), the bone cement used to 
hold the implant in the medullary cavity of the humerus and ulna, has significant problems of 
as well, including tissue necrosis due to high setting temperature and monomer toxicity [2].  
Loose particles of PMMA in living tissue also invoke a negative foreign-body response. 
Elbow implants can be constrained (simple hinge), semi-constrained (loose hinge), or 
unconstrained (articulating components held together by soft tissue) [3].  Constrained 
implants are no longer commonly used because of high failure rates due to aseptic loosening 
[1].  Loosening in constrained implants is caused by the rotational forces borne by the hinge 
and thus the bone cement [3].  Unconstrained implants, and to a lesser extent semi-
constrained implants, are less likely to experience aseptic loosening because the surrounding 
living tissue supports these forces; however, maintaining stability is a concern with 
unconstrained implants [1,3].  Semi-constrained implants are “used in many centers and are 
used routinely by some surgeons” while unconstrained implants have seen little use due to 
the aforementioned concerns [1]. 
There is a need for an elbow implant that effectively transfers load to bone, maintains as 
much living bone as possible, and minimizes negative foreign body response.  This implant 
should be unconstrained, utilize a material to which bone bonds for support, and articulate on 
a wear resistant ceramic to prevent the release of hazardous wear particles.  Such an implant 
has been designed by Dr. Thomas McGee.   
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Research Objective 
The goals of this research are to select the necessary materials and processing techniques, 
and to manufacture and assemble a ball-centered elbow joint replacement prototype.  Bone 
physiology must be considered to ensure a safe and effective implantation. 
Ultimately, this implant will be adapted for use in humans; however, to ensure its safety and 
effectiveness it should be first tested in animals.  Canines are the most logical choice for this 
research because the surgeons at the Iowa State College of Veterinary Medicine are familiar 
with canines and the structure of the canine elbow joint (as shown in [4]) is similar to the 
elbow joint in humans (as shown in [5]).  The development of this new ball-centered elbow 
joint prototype has not yet advanced to the point to begin live trials, but cadaver elbow joints 
have been examined for inspiration. 
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LITERATURE REVIEW 
Use of Animals in Orthopaedic Research [6] 
The use of animal models in orthopaedic research is important to ensure safe performance in 
human clinical trials after in vitro studies have proven successful.  Animal models should 
only be used in circumstances where the information cannot be gained in any other way and 
provides insight into future human trials.  Care must be taken to prevent extraordinary pain or 
disability to the animal.  The knowledge gleaned from animal models can provide immense 
benefit to both humans and animals. 
An and Friedman give six considerations when selecting an animal for orthopaedic research: 
ethics, availability, housing requirements, ease of handling, cost, and susceptibility to 
disease.  With ethics in mind, it is important to use the most primitive animal that will 
provide the desired information.  Pain, disability, and/or distress to the animal must be 
minimized.  Generally, in the United States, availability of animals is not a concern.  Housing 
for a research animal must be provided so the types of animals that can be used for an 
experiment will depend on the available facilities.  The animals could be housed elsewhere, 
however there is great benefit to being able to easily visit and inspect the animals.  Ease of 
handling is one of the main reasons that small animals are used more commonly in research 
than large animals.  In certain cases, larger bones, muscles, or tendons are necessary, which 
requires the use of a larger animal.  Cost, including transportation, housing, etc., should not 
be a decisive factor in choosing an animal, however a cheaper animal can be used, provided 
sufficient data can be obtained.  Many animals are prone to certain diseases and this should 
be taken into account before embarking on a long-term study.  An ill animal can distort data 
and increase total cost.  In some cases it is possible to purchase disease-resistant animals. 
For the research performed in this thesis, a cadaver canine was used.  The materials used in 
the implant have already been proven to be biocompatible, so testing in a living organism at 
this stage is unnecessary.  Cadaver canines are relatively easy to obtain from the Iowa State 
Veterinary Hospital and provide bones large enough to give a reasonable comparison to 
human bone.   
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Anatomy of Bone 
Composition of Bone 
Bone owes its unique combination of strength, durability, and flexibility to a composite 
matrix of organic and inorganic components.  As shown in Table 1, just over two-thirds of 
bone is made up of apatite crystals, which gives bone its hardness [5].  The crystals tend to be 
shaped like spindles (20-40nm by 1.5-3nm) or plates and reside around and throughout the 
collagen fibers [7].  The mineral component is very nearly hydroxyapatite 
(Ca10(PO4)6(OH)2); however, the apatite has a number of impurities including citrate 
(C6H5O7
-4
), carbonate (CO3
-2
), fluoride (F), and hydroxyl ions (OH
-
) [7].  The organic 
component is primarily composed of osteoid, which includes proteoglycans, glycoproteins, 
and collagen fibers [5].  As discussed later in the structure of osteons, collagen fibers are 
responsible for the bone’s tensile and torsional strength. 
Table 1: Composititon of bone. [7] from original source [8] 
Component Amount (wt.%) 
Mineral (Apatite) 69 
Organic Matrix 22 
     Collagen (90-96% of organic matrix) 
     Others (4-10% of organic matrix) 
Water 9 
Structure of Bone [5] 
Bones have high strength and low weight due to their structure based on two “types” of bone: 
compact and cancellous (or spongy).  Compact bone is dense, while cancellous bone, with its 
sponge- or honeycomb-like structure, is much less dense and contains marrow.  A typical 
long bone, such as the femur, has compact bone all around the surface with cancellous bone 
filling in the space at the ends of the bone, known as the epiphyses. In the diaphysis, or shaft, 
of a long bone is the medullary cavity which holds the marrow.   
The surface of compact bone is covered by a white, double layered membrane called the 
periosteum. The periosteum is fixed to the bone matrix by a web of collagen fibers called 
Sharpey’s fibers.  Numerous nerves, fibers, and blood vessels supply the periosteum, which 
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has openings throughout to provide innervation and nutrition to the bone.  Cancellous bone, 
along with internal bone surfaces, is covered by a similar membrane known as the 
endosteum.  Both membranes contain cells known as osteoblasts and osteoclasts (discussed 
in Physiology of Bone section).  Surfaces where the bone contacts other bone(s) are usually 
covered by cartilage, shown as light blue in Figure 1.  Cartilage is similar to bone, but 
receives no blood supply and therefore heals poorly [9]. 
 
Figure 1: Compact and spongy bone in a long bone. [5] 
Compact bone can be broken down into structural units known as osteons or Haversian 
systems.  At the center of each osteon there is a canal that innervates and supports the flow of 
nutrients via blood to the bone.  The osteons are cylindrically shaped (200-250μm diameter) 
with their long axis parallel to the long axis of the bone and are formed by separate layers of 
collagen known as lamellae (3-7μm wide) [10].  The collagen fibers in each lamella run in 
the same direction but the collagen fibers in neighboring lamellae run in the opposite 
direction which helps the bone withstand torsional stresses.  In between the lamellae are 
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osteocytes which lie in small pockets called lacunae.  The osteocytes help to maintain the 
bone matrix.  Canaliculi, which are small channels, run through the lamellae from the central 
canal to all of the lacunae. 
 
Figure 2: A pie shaped slice of an osteon. Adapted from [5] 
Trabeculae, which make up the sponge-like structure of cancellous bone, are not oriented 
randomly, but rather are aligned to best support the stresses imposed upon the bone.  The 
trabeculae are also composed of lamellae with canaliculi and osteocytes.  Cancellous bone 
does not contain osteons; however, cancellous bone does receive nutrition in a very similar 
manner, simply without a central canal.  The nutrition comes from the marrow surrounding 
the trabeculae.   
Mechanical Properties of Bone 
A comparison of the mechanical properties of certain human and canine bones is shown 
below in Table 2.  It is important to note that there are large discrepancies in the values 
reported for the mechanical properties of bone.  There are a number of reasons for this 
disparity, including the lack of uniformity in bone and the manner in which the bone samples 
are stored [11].  One common procedure is to keep the bone samples wet with saline after 
harvesting because dried bones exhibit different properties, for example higher compressive 
strength [11,12].  
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Table 2: Comparison of human and canine bone mechanical properties in MPa.  [12] 
Property Bone Human Canine Note 
Ultimate Compressive 
Strength 
Femur 154 114 middle portion of the 
shaft in the 
longitudinal direction 
Humerus 125 112±2.9 
Radius 115 — 
Ulna 118 — 
Ultimate Bending 
Strength 
Femur 208±7.8 165±5.9 anteroposterior 
direction Humerus 211±4.9 166±7.8 
Radius 227±5.9 174±7.8 
Ulna 225±4.9 174±6.9 
Ultimate Torsional 
Strength 
Femur 45.3 65.7±3.0 human specimens were 
adults Humerus 42.6 66.6±4.3 
Radius 48.5 74.5±6.5 
Ulna 44.6 60.8±5.1 
Elastic Modulus 
Femur 18300 11500 anteroposterior 
bending Humerus 10000 8430 
Radius 15900 9900 
Ulna 15400 17800 
The tests were performed with wet long bone and human specimens were 20-39 years old except where 
otherwise noted.  All values are in units of MPa (converted from kg/mm
2
). 
Physiology of Bone 
Remodeling of Bone [10] 
Adult bone constantly undergoes a process known as remodeling.  Remodeling can be 
thought of as bone turnover, because this process not only repairs microcracks that form in 
the bone, but also continuously removes and deposits bone where necessary.  There are two 
predominant factors that control whether bone is removed or deposited.  The first is Ca
2+
 
homeostasis, which is essentially maintaining the proper balance of Ca
2+
 ions.  The second is 
mechanical stress, which effects remodeling by an unknown mechanism.  As shown in 
Figure 3, bone will deposit or resorb bone to best deal with the stresses imposed upon it, 
following the orthopaedic mantra attributed to Wolff’s law: form follows function. 
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Figure 3: Wolff's law applied to a femur.  Adapted from [10] 
Osteoblasts are responsible for depositing new bone.  Osteoid is secreted onto the bone 
surface and is mineralized over the next 5 to 15 days.  It is currently not understood how the 
osteoblasts regulate the precipitation of hydroxyapatite.  The resorption of bone is performed 
by much larger, multinucleated cells called osteoclasts, which secrete lysosomal enzymes 
and metabolic acids [5].  A small pit, also known as Howship’s lacuna, is formed after 
resorption.  The release of growth factors during resorption causes osteoblasts to move in and 
rebuild the bone after the osteoclasts move to resorb bone elsewhere. About 15% of the 
osteoblasts will become osteocytes in the newly formed bone matrix. 
 
Figure 4: Remodeling of bone. Adapted from [13] 
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Fracture Repair [5] 
According to Marieb, there are four major phases that describe the repair process for a simple 
fracture (clean break under the skin).  The first phase is hematoma formation, due to the 
breaking of blood vessels in and around the bone.  This phase is accompanied by swelling, 
pain, and inflammation.   
In the second phase a fibrocartilaginous callus forms to bridge the gap in the broken bone.  
The fibrocartilaginous callus is a term used to describe all of the repair tissue in the gap 
between the bones.  In this phase phagocytic cells clean up the area while capillaries grow in 
to supply nutrition.  New bone is laid down by fibroblasts and osteoblasts.  Collagen fibers to 
reconnect the bone ends are created by the fibroblasts while the osteoblasts start building a 
matrix of spongy bone.  Osteoblasts further from the nutrition supply and chondroblasts, 
which are differentiated fibroblasts, fill the entire area with a cartilaginous matrix for 
increased support of the break. 
The fibrocartilaginous callus dissolves and is replaced by a bony callus of cancellous bone in 
the third phase.  This conversion is caused by the increasing numbers of osteoclasts and 
osteoblasts in the fibrocartilaginous callus.  The bony callus usually starts to form 3-4 weeks 
after the injury and provides a strong connection after 2-3 months. 
The fourth and final phase is characterized by remodeling of the repaired tissue.  This process 
begins during the third phase and generally continues for several months.  The inside and 
outside of the bone is cleaned up and compact bone is formed.    
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The Synovial Joint [9] 
There are three types of joints: fibrous (synarthroses), cartilaginous (amphiarthroses), and 
synovial (diarthroses).  The first two allow no or very little movement while the latter allows 
a significant range of motion.  The elbow joint is composed of three synovial sub-joints 
(humero-ulnar, humero-radial, and radio-ulnar) all encased in one joint capsule.  The joint 
capsule has two layers, each with its own function.  The outer layer is protective and provides 
strength, while the inner layer dispenses synovial fluid, a thick lubricant for the joint.  
Synovial fluid is also the only medium through which nutrition reaches, and waste is 
removed from, the cartilage in the joint.  Inside the joint capsule are the joint cavity and the 
articulating bones.  The friction between the articulating bones is reduced by hyaline 
cartilage, which covers the articulating surfaces. 
Structure of the Elbow Joint [9] 
The canine elbow is constructed of the same bones as the human elbow, albeit in slightly 
different orientations.  The greatest difference is the location of the radius, which is on top of 
the ulna and inhibits the ability of canines to rotate their elbows significantly.  Canine 
musculature and innervation around the elbow joint can be seen in Figure 7 and Figure 8. 
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Figure 6: (b) Caudal aspect of left humerus.  (c) Cranial aspect of left radius and ulna. [4] 
 
Figure 7: Lateral aspect of left elbow—soft tissue structures of surgical importance [4]. 
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Figure 8: Medial aspect of left elbow—soft tissue structures of surgical importance [4]. 
The three sub-joints of the elbow each provide an important function.  The humero-radial 
joint, between the humerus and radius, carries the majority of load experienced by the elbow. 
Elbow stability and the hinge-like motion of the elbow joint are maintained by the humero-
ulnar joint, between the humerus and ulna [9,4].  The final elbow joint, the proximal radio-
ulnar joint, is located between the radius and ulna and allows for rotation of the elbow.   
The stability of joints is improved by the presence of ligaments, which are bands of 
connective tissue originating and terminating in bone.  Ligaments, like cartilage, are 
avascular.  This means a partially detached or torn ligament cannot heal well-enough to 
provide as much stability as an uninjured ligament.  Lateral movement of the elbow is 
restrained by the collateral ligaments and the fit of the anconeal process into the olecranon 
fossa (see Figure 9) [4].  The annular ligament surrounds and keeps the radius against the 
ulna during rotation.  Hyperextension of the elbow is likely resisted by the oblique ligament 
while separation of the olecranon and humerus is prevented by the olecranon ligament. 
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Figure 9:  Lateral aspect of the left elbow: (a) Lateral collateral ligament; (b) Annular ligament; (c) 
Oblique ligament; (d) Olecranon ligament. [4] 
Materials 
For a material to be considered a biomaterial it must be able to safely and reliably replace 
and/or function in living tissue with an appropriate physiological response [7].  In other 
words, the material must be biocompatible.  There are four groups of synthetic biomaterials: 
polymers, metals, ceramics, and composites [7].  For this research only polymers were not 
used, which are commonly used as the articulating surfaces and as bone cement in 
conventional implants.   Both of these applications of polymers have been replaced with 
ceramics. 
Alumina 
Single crystal alumina is hard and strong but is too brittle to be used as an articulating 
component (see APPENDIX I).  Like most ceramics, the strength of polycrystalline alumina 
can be improved by decreasing porosity and grain size [7].  Grain growth can be hindered by 
adding MgO (less than 0.5wt%) [14].  An alumina implant must have a flexural strength 
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greater than 400MPa and an elastic modulus of 380GPa to meet ASTM standards F603-78 
[7].  Alumina’s advantages over metals and other ceramics are its low friction surface and 
wear resistance, making it a useful material for articulating surfaces.  Grains must be smaller 
than four microns with little variation in size to prevent pull-outs and maintain high wear 
resistance [14].  For joint implants the articulating components are polished against each 
other to ensure a smooth surface and a good fit.  Alumina has excellent corrosion resistance 
and only prompts thin capsule formation.  
Zirconia 
Zirconia is commonly doped with magnesia and/or yttria to stabilize its higher temperature 
phases (tetragonal then cubic) [7].  This is necessary to prevent the large volume expansion 
that occurs when tetragonal or cubic zirconia transforms to the room temperature monoclinic 
structure [7,15].  If zirconia is not stabilized, or sintered below the tetragonal-monoclinic 
transformation, it will almost certainly develop cracks and fail during cooling [15]. 
The presence of the metastable tetragonal phase improves the fracture toughness of zirconia 
through crack growth retardation [7].  The stresses induced during crack propagation cause 
the tetragonal particles to transition to the monoclinic phase, increasing their volume and 
closing the crack.  Yttria-stabilized zirconia (YSZ) is often used instead of alumina because 
of its superior fracture strength, fracture toughness, and wear resistance against ultrahigh-
molecular-weight polyethylene.  It is important to note, however, that an alumina-alumina 
articulating component wears significantly less than zirconia-zirconia.  Zirconia’s 
biocompatibility is similar to alumina.   
Unfortunately, these benefits are not without side-effects: YSZ is susceptible to low-
temperature degradation (LTD) in moist environments [15].  LTD causes the transformation 
from tetragonal to monoclinic to occur without the presence of a crack, resulting in “surface 
roughening, microcracking, and grain pull-out as well as loss of strength”.  Grain size, pore 
structure, and yttria content all have an effect on the likelihood of LTD occurring.  Doping 
zirconia with certain other stabilizers, such as ceria, or using a two phase zirconia composite, 
such as alumina-zirconia, is an effective method to reduce susceptibility to LTD. 
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Table 3: Comparison of properties of alumina and zirconia. [7] from original source [16] 
Property Alumina Zirconia 
Chemical composition Al2O3+MgO ZrO2+MgO+Y2O3 
Purity (%) 99.9 95~97 
Density (g/cm
3
) >3.97 5.74~6.0 
Porosity (%) <0.1 <0.1 
Bending strength (MPa) >500 500~1000 
Compression strength (MPa) 4100 2000 
Young's modulus (GPa) 380 210 
Poisson's ratio 0.23 0.3 
Fracture toughness (MPa*m
1/2
) 4 up to 10 
Thermal expansion coefficient (*10
-6
/K) 8 11 
Thermal conductivity (W/m*K) 30 2 
Hardness (HV0.1) up to 2200 1200 
Contact angle (°) 10 50 
 
Calcium Phosphates 
As mentioned previously, the majority of bone is composed of minerals, most notably an 
impure form of hydroxyapatite.   Because of this, synthesized hydroxyapatite has superb 
biocompatibility [7].  Stoichiometric hydroxyapatite is monoclinic [17]. It has lattice 
parameters a = 9.4214(8), b = 2a, c = 6.8814(7) A, γ = 120° with a space group symmetry of 
P21/b.  In stoichiometric hydroxyapatite, the OH
-
 ions form ordered columns (i.e. OH OH 
OH OH); however, sufficient impurities allow a disordered column structure by giving a 
point of reversal in the column, for example an F
-
 impurity would allow OH OH F HO HO.  
In this nonstoichiometric case the structure of hydroxyapatite is hexagonal. 
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Another important calcium phosphate is tricalcium phosphate.  Tricalcium phosphate has a 
high temperature phase (α, monoclinic), and a low temperature phase (β, rhombohedral) [17].  
The calcium to phosphorus (Ca:P) ratio and formula for these and other calcium phosphates 
can be found in Table 4.  The Ca:P ratio is important because as it decreases, the solubility of 
the mineral in the body increases (i.e. tricalcium phosphate will dissolve faster than 
hydroxyapatite) [14].  The solubility isotherms of common calcium phosphates are shown in 
Figure 10.  At the normal body pH of around 7, it is easy to see that hydroxyapatite is the 
most stable calcium phosphate. 
The difference in solubility between hydroxyapatite and tricalcium phosphate is useful 
because it allows an implant or bone filler to dissolve away; however, care must be taken to 
ensure that the rate of dissolution is similar to the rate of new bone growth [14].  Factors that 
increase the rate of dissolution include: increasing surface area, decreasing crystallinity, 
decreasing crystal perfection, and decreasing crystal and grain size.  The solubility of 
hydroxyapatite increases with ionic substitutions of CO2
-3
, Mg
2+
, and Sr
2+
, but decreases with 
F
-
 substitution. 
Table 4: Calcium Phosphates. [14] 
Ca:P Mineral Name Formula Chemical Name 
1.0 Monetite CaHPO4 Dicalcium phosphate (DCP) 
1.0 Brushite CaHPO4·2H2O 
Dicalcium phosphate dihydrate 
(DCPD) 
1.33 - Ca8(HPO4)2(PO4)4·5H2O Octocalcium phosphate (OCP) 
1.43 Whitlockite Ca10(HPO4)(PO4)6 
 1.5 - Ca3(PO4)2 Tricalcium phosphate (TCP) 
1.67 Hydroxyapatite Ca10(PO4)6(OH)2 
 2.0 - Ca4P2O9 Tetracalcium phosphate 
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Figure 10:  Solubility isotherms of calcium phosphates at 37°C calculated with the program RAMESES.  
Some of the abbreviations are given in Table 4, others signify: DCPA – dicalcium phosphate 
anhydrous (monetite), OHAp – hydroxyapatite.  Note that normal body pH is just over 7. [17] 
Stainless Steel [7] 
The most common type of stainless steel used for implants is 316L (ASTM F138, F139) [18].  
The inclusion of 2.25-3.00wt.% molybdenum improves salt water corrosion resistance, while 
the drop in carbon content from 0.08wt.% to 0.03wt.% maximum improves chloride solution 
corrosion resistance.  Heat treatment and cold working can have a dramatic impact on the 
mechanical properties of stainless steel (see Table 5).  The grain size of 316L should be 100 
microns or less [18].  In humans, stainless steel is generally only used for temporary fixation, 
for example bone screws and nails, because it is still susceptible to corrosion in certain 
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situations, such as in highly stressed and oxygen depleted regions.  Stainless steel is 
appealing for implant use in animals, however, due to their shorter lifetimes and the lower 
price compared to cobalt-chrome and titanium alloys. 
Cobalt-Chromium Alloys [7] 
The two cobalt-chromium alloys most often used to manufacture implants are CoCrMo 
(ASTM F75) and CoNiCrMo (ASTM F562).  CoCrMo is castable and commonly used in 
dentistry and artificial joint applications, while CoNiCrMo is hot forged and usually used as 
the stem of joint replacements in legs.  The properties of CoCrMo can be improved by hot 
isostatic pressing [18].  The addition of molybdenum gives the alloy better strength by 
hindering grain growth.  Both alloys wear at similar rates, but CoNiCrMo alloy is not used as 
an articulating surface because it has inferior frictional properties.  Cobalt-chromium alloys 
have the highest elastic moduli of common implant metals.  The corrosion resistance of 
cobalt-chromium alloys is superior to stainless steel, but inferior to titanium alloy. 
Titanium Alloys 
Pure (98.9-99.6%) titanium (ASTM F67) has four different grades, correlating to a rise in 
impurity content [18].  These impurities, such as oxygen, carbon, and nitrogen, greatly affect 
the mechanical properties of titanium through interstitial solid solution strengthening (see 
Figure 11).  Nitrogen gives about twice the strengthening effect per atom, but oxygen content 
varies the most between the grades, rising from 0.18% (grade 1) to 0.40% (grade 4).  
Hydrogen impurities can damage the ductility of titanium through the formation of hydrides 
[19].  Because of this the maximum amount of hydrogen allowed in titanium is 0.015wt%.  
Cold working has been shown to increase the fatigue strength of titanium [18].  The fatigue 
strength of pure titanium is far inferior to alloyed titanium, however (see Table 5). 
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Figure 11:  Effect of impurities on pure titanium.  “Data of Jaffee are for samples annealed at 850°C; 
those of Finlay are for samples annealed at 700°C.”  TS and YS refer to tensile and yield 
strength respectively. [19] 
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Ti-6Al-4V (ASTM F136) is a very common titanium alloy used in implants [7].  Aluminum 
and vanadium are the largest alloying elements in Ti-6Al-4V at 5.5-6.5wt% and 3.5-4.5wt% 
respectively.  The aluminum further stabilizes the stable, low temperature alpha phase (HCP) 
while vanadium stabilizes the metastable, high temperature beta phase (BCC) [19].  The 
alloy’s properties can be better controlled by this two phase structure, with aluminum (alpha 
stabilizer) improving solid solution hardening and vanadium (beta stabilizer) lowering the 
temperature required for heat treatment. 
Ti-6Al-4V has the largest specific strength, or strength per density, of any metallic implant 
material and also has the lowest elastic modulus [7].  Like pure titanium, Ti-6Al-4V is 
strongly affected by hydrogen, oxygen, carbon, and nitrogen impurities [18].  Ti-6Al-4V 
alloy is generally not used for temporary fixation because of its low shear strength, nor is it 
used as an articulating surface because it has a propensity to gall or seize [7].  Pure titanium 
and Ti-6Al-4V owe their exceptional corrosion resistance to the thin layer of TiO2 on their 
surface. 
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Bone Cements 
Bone cement is used during implantation to ensure the joint replacement is securely held in 
the bone cavity.  Currently, the most commonly used bone cement is composed 
predominantly of poly(methylmethacrylate) (PMMA).  Unfortunately, the failure rate of 
these bone cements is close to 10% within ten years post-operation [2].  After failure, a 
revision operation is necessary to re-secure or repair the implant, resulting in extra costs and 
pain to the patient.  A significant improvement to, or a replacement of, PMMA bone cement 
would be a boon to joint replacement operations. 
PMMA Cement 
PMMA bone cement is mixed from a liquid component, containing methyl methacrylate 
monomer, and a solid powder, containing of poly(methylmethacrylate), each with several 
additives [7].  The liquid contains two additives to prevent early polymerization and improve 
curing of the cement at lower temperature and pressures than those used to produce dental 
implants.  The solid component contains a radiopacifier and the free radical initiator.  During 
mixing, the liquid wets the powder surface and polymerization occurs by a free radical 
process.  The monomers grow into long chain polymers and polymerization continues until 
all of the initiator is consumed. 
After mixing, PMMA bone cement must have a dough, or working, time of no more than 5 
minutes, a setting time range of 5-15 minutes, and a final temperature less than 90°C [7].  
Reported tensile and compressive strength values for different brands of PMMA bone cement 
vary from 13.2 to 48.2 MPa and 72.6 to 120 MPa [2].  Parks and Lakes [7] mention many 
intrinsic and extrinsic factors which may affect the final properties of PMMA bone cement, 
“composition of monomer and powder; powder particle size, shape, and distribution; 
liquid/powder ratio; mixing environment; mixing technique; and curing environment.”   
PMMA bone cement has several critical drawbacks [2].  Temperature rise during setting can 
cause necrosis of surrounding bone tissue if maximum temperature surpasses 56°C.  Damage 
to cells can also begin at 48°C depending on exposure time.  Reported max temperature 
values for the bone-bone cement interface vary substantially, but it is common for at least 
24 
 
one of the two given temperature criteria to be surpassed.  Other concerns include monomer 
toxicity and negative foreign-body response to wear or fractured particles of the cement.  
This foreign-body response may cause aseptic loosening of the implant.   
Ceramic Cement 
Calcium Orthophosphate Cements [20] 
These cements are created by mixing one or more calcium orthophosphate powder with an 
aqueous solution such as distilled water or phosphate-buffered saline.  The mixed powders 
become a thick paste which can be molded into place and then set minutes later.  The 
powder-to-liquid ratio of the cement controls the ease of injection and bioresorbability of the 
hardened cement.  Dorozhkin points out the many advantages of calcium orthophosphate 
cements: fast setting time, excellent moldability, outstanding biocompatibility, easy 
manipulation, and perhaps most importantly, they are osteotransductive (i.e. the cement is 
slowly replaced by new bone tissue).  Unfortunately, ceramic cements are brittle and as such 
are weak under tensile forces.  This means that calcium orthophosphate cements must be 
used in conjunction with a metal implant or where load-bearing is not a criterion.   
Calcium orthophosphate cements have been split into two major groups depending on the 
end product after setting.  When the pH of the cement is greater than 4.2 either a poorly 
precipitated crystalline hydroxyapatite or calcium-deficient hydroxyapatite (Ca10-
x(HPO4)x(PO4)6-x(OH)2-x where 0<x<1) forms, leading to this group’s name of apatite 
cements.  Brushite cements are formed at a pH below 4.2 and form dicalcium phosphate 
anhydrous (see Table 4 for formula).  For both groups, the powders first dissolve into 
solution where the ions interact and then precipitate, resulting in the cement setting.  
According to Dorozhkin, “during precipitation the newly formed crystals grow and form a 
web of intermingling microneedles or microplatelets of the final products, thus provide a 
mechanical rigidity to the hardened cements.”  It should also be noted that calcium 
orthophosphate cements set primarily by two types of reactions: classical acid-base 
interaction and hydrolysis in an aqueous solution.  The latter reaction uses a single 
metastable calcium orthophosphate powder, rather than a mixture. 
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Setting time is also an important characteristic that must be controlled.  During surgery, the 
surgeon must have enough time to place the cement before it hardens, without having so 
much time that the operation is delayed.  For calcium orthophosphate cements in orthopaedic 
applications, working time should be roughly 8 minutes and the cement should be set by 15 
minutes. 
Osteoceramic Cement 
To improve the strength of calcium orthophosphate cements and make them a viable 
alternative to PMMA, composite cements have been developed.  Calcium orthophosphate 
powders can be mixed with biocompatible calcium salts to create cements with various 
property changes [20].  Of note is a mixed calcium orthophosphate and calcium aluminate 
cement.  A novel version of this cement, called osteoceramic cement (OC-cement), is 
composed of 33wt.% β-tricalcium phosphate and 66wt.% calcium aluminate, which is mixed 
with calcium chloride solution [21].  The components are mixed with vibration to improve 
mixing and expel trapped air.  This cement has a working time of about 6 minutes and a 
setting time of 12-13.5 minutes at 37°C.  Temperature increase during setting for OC-cement 
is much lower than for PMMA cement, with a maximum temperature increase of 15.5°C 
when tested at 22°C.  The compressive strength of OC-cement over time can be seen below 
in Figure 12.   
 
Figure 12: Compressive strength of OC-cement over time. [21] 
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Pull-out tests were performed to compare the interfacial shear strength of OC-cement to 
PMMA cement and it was determined that the differences between the mean strengths were 
not statistically significant; however the means for PMMA did slightly outperform the OC-
cement at each time interval [21].  The tensile strength of OC-cement was found to be 
7.02MPa and 11.34MPa at 24h and 1 week respectively, which is about 1/3-1/2 of common 
PMMA values. 
During a 14 month test suspended in simulated physiological conditions, it was found that 
the mass of the OC-cement increased by 8.23% while its volume expanded 0.71% [22].  
These changes are due to the hydration and conversion of the cement components.  
Roemhildt [22] suspects this slight increase in volume may enhance stability by preventing 
loosening, which is a problem in PMMA cements as they shrink after polymerization.  OC-
cement is dilatant and requires vibration during injection.  This can be a benefit in certain 
circumstances, but does require a different procedure than standard PMMA cement 
protocols. 
Design of Current Implants 
The elbow implant discussed in this thesis was designed for use in canines; however, the 
ultimate goal is a design suitable for human use.  Because of this, it is relevant to understand 
the functionality of currently used human and canine implants.  The proposed ball centered 
elbow joint implant design will be modified for eventual human use after canine 
implementations have proven successful. 
Canine Elbow Implant 
As of 2009 the canine total elbow produced by BioMedtrix had been used for over 10 years, 
with approximately 750 implants shipped [23].  The implant utilizes an unconstrained design 
in two components: humeral and radioulnar (see Figure 13) [3].  The humeral component is 
made of 316L stainless steel, while the radioulnar component is formed from medical grade 
ultrahigh-molecular-weight polyethylene.  On the humeral component, articulating surfaces 
were polished and other surfaces were bead blasted to give a rough finish.  The radioulnar 
component has two stems to anchor it into the medullary cavities of both the radius and ulna.  
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The design allows for a theoretical range of 15° of flexion to 170° of extension; however it 
also calls for radioulnar synostosis, or bone fusion, which prevents useful rotation of the foot.  
The current success rate for this implant is 80% [23]. 
 
Figure 13: BioMedtrix total elbow implant showing cranial (left) and sagittal (right) views. [23] 
A brief description of the surgical procedure described by Conzemius et al is as follows [3].  
The elbow joint is approached caudolaterally and soft tissue is manipulated so that the radius 
and ulna can be moved to allow access to the humeral condyle.  A hole is drilled through the 
trochlear notch into the medullary canal and the articulating surfaces of the humerus are 
removed.  The excised bone is saved and used later to promote synostosis of the proximal 
radius and ulna.  The articulating surfaces of the radius and ulna are then removed, followed 
by drilling holes into their medullary canals.  PMMA cement is used to hold the implant 
stems in place in their respective medullary canals.  Finally, the joint is put back together, the 
saved bone is placed between the radius and ulna, and the wound is closed. 
Human Elbow Implant 
The Coonrad-Morrey total elbow (see Figure 14) manufactured by Zimmer was used for 102 
elbow arthroplasties in 86 patients over 13 years at a single institution [1].  According to a 
brochure available on the company website, the implant has an ulnar stem and a humeral 
stem each made of Tivanium® Ti-6Al-4V alloy, which are connected via a pin with an 
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ultrahigh-molecular-weight polyethylene bushing [24].  Portions of the stems are plasma 
spray coated to provide a rough surface to improve bone cement adherence.  There is a flange 
on the proximal end of the humerus to hold a bone graft with the intention of improving the 
thickness of the bone locally.  Shi et al found the five year success rate for this implant to be 
72%, which is much lower than was found by the Mayo Clinic: 94.4% for rheumatoid 
arthritis and 80% for posttraumatic arthritis [1].  It is possible the broader definition of failure 
used by Shi et al may account for the difference.  The most common source of failure in the 
study by Shi et al was implant loosening. 
 
Figure 14: Zimmer Coonrad/Murrey total elbow. [24] 
The surgical procedure for the human elbow implant is very similar to the canine procedure, 
but has several key differences.  According to the surgical technique guide provided on 
Zimmer’s website, the radius is mostly untouched during the procedure and a bone graft is 
wedged under the humeral flange; no bone graft is used to merge the proximal ends of the 
radius and ulna [24].  Because the implant is semiconstrained (i.e. humerus and ulna are 
connected by a pin), collateral ligaments do not need to be reattached. 
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MATERIALS AND METHODS 
Zirconia-Toughened Alumina 
The most important properties for the ball, radius base, and ulna base are fracture toughness 
and wear resistance.  As mentioned previously, zirconia has better fracture toughness while 
alumina has the better ceramic-ceramic wear resistance.  In order to avoid the drawbacks of 
zirconia, but gain its superior fracture strength, zirconia-toughened alumina (ZTA) was 
selected for the articulating surfaces.  Low-temperature degradation (LTD) susceptibility is 
far less in ZTA because the zirconia phase is not interconnected throughout, so moisture 
diffusion is difficult, and the stiffer alumina matrix resists the transformation to the larger 
monoclinic phase [15]. 
It has been shown that alumina doped with 2.5wt.% zirconia has superior wear resistance to 
monolithic alumina at loads under 50N [25].  In fact, at a load of 20N ZTA wears an order of 
magnitude less than monolithic alumina.  At loads higher than 50N, ZTA and monolithic 
alumina wear at similar rates.  Not only does wear resistance increase, but also strength and 
toughness nearly doubled over the values for monolithic alumina. 
Schehl, Díaz, and Torrecillas [26] investigated the mechanical properties of 5wt.% ZTA 
compared to high purity alumina.  The results of this research can be seen in Table 6.  It is 
easy to see that the fracture toughness of ZTA is far superior to alumina and approaches the 
fracture toughness values commonly seen for zirconia.   
Table 6:  Properties of high purity alumina and 5wt.% ZTA. Sintered at 1600°C for 2 hours. [26] 
Material Young’s Modulus 
(GPa) 
Bending Strength 
(MPa) 
Fracture Toughness 
KIC (MPa
.
m
1/2
) 
High purity alumina 400 326 4.5 
5wt.% ZTA 381 343 7.5 
For this implant, alumina was doped with 5wt.% zirconia.  The standard operating procedure 
for doping the alumina via a powder-alkoxide mixture (given in APPENDIX II) was 
developed using the specifications given by Schehl, Díaz, and Torrecillas [26].  Ceramic 
processing is described in a later section. 
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Osteoceramic 
Osteoceramic is a ceramic-ceramic composite developed by Thomas McGee [27].  It is a 50-
50 by volume mixture of calcium phosphate tribasic and MgAl2O4 spinel [28].  The calcium 
phosphate provides bioactivity while the spinel provides a strong backbone to maintain 
strength as the calcium phosphate phase interacts with living tissue.  This two phase structure 
is critical for a successful ceramic implant because the flaw structure of a bioactive ceramic 
on its own cannot be controlled.  In the case of osteoceramic, the spinel, a bioinert ceramic, 
maintains its original flaw structure as the calcium phosphate phase dissolves.  Additionally, 
the constituent ions of spinel have significantly different atomic radii from calcium 
phosphate, which should limit solid solubility and allow an interconnected pore structure to 
form. 
X-ray diffraction analysis and energy dispersive analysis on an SEM of osteoceramic sintered 
at 1500°C show two separate phases: α-tricalcium phosphate and MgAl2O4 spinel [28].  
Electron micrographs of osteoceramic sintered at 1500°C are shown below in Figure 15 and 
Figure 16.  The first image shows polished osteoceramic with the harder spinel phase at a 
higher elevation.  The second image shows an osteoceramic surface treated with 8% ethylene 
diamine-tetraacetate (EDTA) for 20 minutes.  This process etched away the calcium 
phosphate phase allowing the cubic spinel phase to be clearly seen. 
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Figure 15:  SEM micrograph of polished osteoceramic surface. (x3500) [28] 
 
Figure 16:  SEM micrograph of osteoceramic surface etched with EDTA.  The calcium phosphate phase 
has been removed. (x5000) [28] 
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The compressive strength of 1450°C sintered osteoceramic is 199MPa [29].  It has a Young’s 
Modulus of 114GPa which is very similar to that of titanium and its alloys.  The porosity of 
osteoceramic is 8.32% and is well dispersed, with pore diameter ranging from 1.5-2.0 
microns.  Importantly, there is essentially no open porosity, which, when present, can wick or 
carry bodily fluids through the ceramic [28]. 
Keller [30] examined the in vitro biocompatibility of osteoceramic with osteoblast-like cells 
from rat pups.  Three different surfaces of osteoceramic (polished, roughened by etching, and 
as-fired), along with a 24-well tissue culture plastic plate as a control, were exposed to these 
cells for 120 minutes.  A micrograph of an osteoblast attached to the as-fired surface of 
osteoceramic can be seen in Figure 17.  All surfaces had significant cell attachment, with the 
most on the rough surface and statistically equivalent attachment on the other three surfaces 
(see Figure 18).  Keller notes that neither pure nor alloyed titanium have had osteoblast-like 
cell attachment greater than or equal to that of the tissue culture plastic plate. 
 
Figure 17:  SEM micrograph of osteoblast-like cell on as-fired surface of osteoceramic. (x2000) [30] 
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Figure 18:  Osteoblast-like cell attachment to osteoceramic surfaces and control (TCP) after 120 minutes.  
Asterisk denotes statistically significant cell attachment. [30] 
Two in vivo experiments in canines have proven that osteoceramic can induce bone growth 
and attachment [29].  The first was an osteoceramic bone graft with special geometry to 
guide bone regeneration and ensure bone attachment; new trabecular bone grew into its 
grooves and new compact bone grew around the implant.  One dog had the implant for over 
eleven years and CAT scans showed that the compact bone of the operated limb was 50% of 
the unoperated limb, which lead to the conclusion that the implant and bone combined 
provide enough strength for a normal canine lifestyle. 
The second experiment was induced diaphysis regeneration using osteoceramic tubes in the 
medullary canal to span a large gap in the diaphysis of nine canines [29].  The three control 
(no implant) dogs’ femurs did not grow back together, but four other dogs had induced 
regeneration across the implant, with mineralized bone across the implant at the time of first 
radiograph (33-51 days depending on the dog). The two other dogs had bone bonding at the 
interface, although after removing half of the bone screws, induced bone regeneration across 
the implant took place in one of the dogs.  
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Figure 19:  Microradiographs of a dog femur from the induced diaphysis regeneration experiment. [29] 
(A) Postoperative 
(B) 3 months 
(C) 5 months 
(D) and (E) 7 months immediately after removal of the plate and screws 
(F) and (G) 11 months 
(H) Medial-lateral section showing some transfer of load to the implant by trabecular bone. 
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Cold Isostatic Pressing 
Both the osteoceramic and ZTA powders were formed into green bodies using cold isostatic 
pressing.  Prepared tubes of powder (see APPENDIX IV) were isostatically pressed to 
20000psi (137.9MPa).  The formed rods measure approximately 100mm long by 20mm 
diameter. 
Catheter Grade Osteoceramic Bone Cement 
OC-cement has excellent properties; however, because it requires vibration to flow, its uses 
are diminished, especially because surgeons would prefer an injection method similar to the 
one used for PMMA cement.  Catheter grade OC-cement (CGOC-cement) was developed to 
meet this need.  CGOC-cement has properties very similar to those of OC-cement, but can be 
injected through a catheter tip syringe. 
CGOC-cement is made by adding a small amount of flow-enhancing powders to the OC-
cement formula.  The powders are ground together in a mortar and pestle and then mixed 
with 2M CaCl2 solution in a metal cup.  The metal cup is vibrated during mixing to ensure 
thorough mixing.  The cement is mixed for about two and a half minutes before it is scooped 
into a 60mL catheter tip syringe for injection (total time is about four minutes). 
The strength of CGOC-cement has been tested in unpublished data.  Cylinders of CGOC-
cement with dimensions 18mm long by 12mm diameter were cast and set for 15 minutes.  
Then they were placed in a sealed bag with Ringer’s solution and left in a hot water bath at 
37°C until the designated testing time.  After 45 minutes average compressive strength has 
surpassed 20MPa and after 24 hours strength has increased to close to 80MPa.  Average 
compressive strength at 5 days is over 100MPa. 
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Materials Characterization 
Linear Shrinkage, Density, and Porosity 
Linear shrinkage and density were determined in tandem.  Rods of Osteoceramic and ZTA 
were cold isostatic pressed and fired to machining temperature (1200°C for Osteoceramic 
and 1000°C for ZTA).  The rods were machined into smooth cylinders and then cut into a 
handful of smaller cylinders with a Buehler Isomet low speed diamond saw.  The heights, 
diameters, and masses of the cylinders were measured, allowing an approximate density to be 
calculated. 
After firing the Osteoceramic and ZTA cylinders to 1450°C and 1650°C respectively, they 
were measured again and the results were compared to the previous measurements to 
calculate linear shrinkage.  In the fully sintered state, the bulk density of the cylinders could 
be determined by use of an Archimedes’ apparatus.  The weight of each cylinder when all the 
pores are filled with water (saturated mass, ms) and the weight when all the pores are filled 
with water and the cylinder is suspended in water (saturated suspended, mss) were determined 
in order to calculate multiple materials properties.  
Tensile Strength 
In order to determine the tensile strength of the ZTA ceramic, a diametral test was used.  This 
test uses compression to create tensile forces that are at a maximum at the center of the disk, 
perpendicular to the compressive axis. Tensile strength was calculated from the max load by 
using the equation provided by Reed [31]. 
   
   
   
 
Where    = engineering tensile strength (Pascals) 
   = Max load (Newtons) 
  = diameter (meters) 
  = height (meters) 
Disks of ZTA were made in the same manner as in the previous section: rods of ZTA were 
machined and then cut into disks with a slow speed diamond saw.  Before firing to 1650°C 
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(fully sintered), the disks were polished to 600 grit.  The fully fired disks were polished down 
to 6 micron with diamond paste.  The height and diameter of each disk was then taken. 
The disks were compressed with an Instron 4204 mechanical testing instrument.  Clear tape 
was wrapped around each disk to hold the broken pieces together after failure.  Each disk 
was set on its short edge and enclosed in a piece of cardboard to evenly distribute load over 
the contact surface.  An aluminum block was used to ensure the disk was set vertically.  The 
entire assembly (see Figure 20) was placed in a plastic bag to keep the broken pieces 
contained.  The disk was kept vertical by applying hand pressure to the aluminum block 
while a small load (1-3kN) was placed on the disk to hold it in place.  Then the aluminum 
block was removed and the test continued at a rate of 1mm/min until the disk broke.   
 
Figure 20:  Diametral testing assembly 
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RESULTS AND DISCUSSION 
Ceramic Processing 
Originally the ZTA was mixed with water to create slip and cast on a plaster of Paris plate; 
however, the slip cast specimens did not have sufficient strength at 1000°C for machining.  
Isostatically pressed ZTA has sufficient strength for machining after firing to 1000°C.  
Higher sintering temperatures than 1000°C make machining very difficult.  Osteoceramic 
rods were also formed via isostatic pressing.  A description of the cold isostatic pressing 
procedure is given in a previous section (Page 35). 
The osteoceramic and ZTA rods are then fired to 1200°C and 1000°C respectively (see 
APPENDIX V) to strengthen them for machining.  After the specimens have been machined 
into appropriate oversized dimensions they are fired to their final temperature: 1450°C for 
osteoceramic and 1650°C for ZTA (see APPENDIX V).  The dimensions of these fully fired 
specimens were used to machine the metal components to ensure proper fit. 
Materials Characterization 
Linear Shrinkage, Density and Porosity 
Results and calculations used to determine a multitude of properties are shown in the table on 
the following page.  
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Table 7: Linear shrinkage and density of osteoceramic and ZTA. 
Property Equation Osteoceramic ZTA 
Linear Shrinkage  
(machinable to fully sintered) 
      
   
     
17.8% 21.6% 
Calculated Density 
(machinable) 
  
      
 1.94  
   
 2.27  
   
 
Calculated Density  
(fully sintered) 
  
      
 3.13  
   
 4.01  
   
 
True Density      — 3.37
a
 
 
   
 4.05
b  
   
 
Bulk Density      
     
      
 
3.12  
   
 4.03  
   
 
Apparent Density      
     
      
 
3.22  
   
 4.04  
   
 
Open Pore Porosity       
     
      
     
2.93% 0.24% 
Closed Pore Porosity       
(  
  
  
 
   
   
)      
4.37% 0.25% 
Percent Theoretical Density 
  
  
     
92.7% 99.5% 
Number of Samples — 9 11 
 
Note:     is length after machining temperature firing. 
     is length after final firing (fully sintered). 
    is the dry mass of a specimen. 
    is the density of the submerging liquid. 
 
a
From [29] 
 
b
Calculated from relative specific volumes based on mass. 
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Tensile Strength 
The diametral testing went smoothly; however, sample 6 broke while the small load (1-3kN) 
was applied.  Average max load and tensile strength were found to be 23.05kN and 393MPa 
respectively.  All of the samples broke catastrophically into many small pieces except for 
sample 4, which showed vertical lines of stress (see Figure 21).  The shattering into tiny 
pieces was likely due to the fact that the sample held so much strain energy that an enormous 
number of surfaces had to be created to relieve the energy.  The fracture pattern of sample 4 
was expected and the initial fracture pattern of all the other samples would have started with 
a similar pattern before fracturing more to relieve excess energy.  The results of the testing 
can be seen below in Table 8. 
 
Figure 21:  Diametral sample 4 after fracture. 
Table 8:  Diametral testing results. 
Test 
No. 
Diameter 
(mm) 
Height 
(mm) 
Max Load 
(kN) 
Tensile Strength 
(MPa) 
1 13.05 2.90 20.66 348 
2 13.08 3.20 25.78 392 
3 13.10 2.80 27.07 470 
4 13.10 3.05 16.91 269 
5 13.09 2.91 22.23 372 
6 13.12 2.88 Broke during placement (<3kN) 
7 13.05 2.48 19.25 379 
8 13.08 2.82 25.73 444 
9 12.08 3.00 26.74 470 
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Scanning Electron Microscopy 
One of the fractured pieces from the diametral testing was thermally etched at 1470°C for 15 
minutes (recommended by [32]).  The specimen was analyzed under an SEM to observe 
grain size and zirconia distribution, and to estimate experimental zirconia percentage using 
energy dispersive spectroscopy (EDS).  The fracture surface of an unetched sample was also 
examined.  In order to observe the samples at high magnification, a 5 micron layer of iridium 
was sputtered onto the surface of the samples to prevent charge build-up. 
EDS estimated the weight percent of zirconia in alumina to be 4.98 to 6.38wt.% (average: 
5.90wt.%).  This is reasonably close to the target of 5wt.%, especially because the accuracy 
of EDS is lower at lower phase concentrations.  Micrographs of the etched sample revealed 
that the zirconia phase is located within the grains as well as at grain boundaries (see Figure 
22).  The zirconia particles are roughly similar in size (~0.5 micron) and tend to be spherical 
when inside a grain and elongated when located on a grain boundary.  By drawing lines on a 
micrograph and counting the grain boundaries, the alumina grain size was determined to be 
1.5 microns.  There is a wide variation in grain size, however, with a few grains larger than 
10 microns and many less than 1 micron. 
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Figure 22:  SEM micrograph of thermally etched ZTA. x5000 
Analysis of the unetched fracture surface indicates predominantly intergranular fracture.  It 
appears that a given crack has to change directions multiple times to propagate, which 
increases the energy of fracture.  Figure 23, Figure 24, and Figure 25 each show the fracture 
surface at different magnifications. 
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Figure 23: SEM micrograph of an unetched fracture surface. x1500 
 
Figure 24: SEM micrograph of an unetched fracture surface.  x5000 
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Figure 25: SEM micrograph of an unetched fracture surface.  x15000 
 
Design of the Implant Prototype 
This new implant was designed to provide two primary improvements over current implants: 
reduce the amount of removed/damaged bone and return full/natural movement to the elbow 
joint while minimizing wear.  In order to accomplish these goals, an unconstrained ceramic 
ball-centered design was adopted to provide proper arm rotation and bending while a 
revolutionary new surgical procedure, coupled with implant design, could significantly 
reduce the amount of excised bone.  More discussion on the implant and surgical instrument 
design can be found in APPENDIX VI.  The ball-centered elbow implant has three major 
subassemblies, one for each bone that makes up the elbow joint, and the schematics for each 
can be seen in APPENDIX VII. 
Stainless steel (316L) was selected as the material for the metal components.  The Ti-6Al-4V 
alloy would have been the superior metal due to its high fatigue and yield strength, along 
with its superior corrosion resistance; however, the cost of the material and its difficulty to 
machine made it nonviable for this canine prototype.  Stainless steel has more than adequate 
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properties for a canine implant and is far less expensive and easier to machine than Ti-6Al-
4V. 
Zirconia-toughened alumina was selected for the articulating components of the implant.  As 
discussed previously, ZTA provides improved fracture toughness over alumina and superb 
wear resistance.  Zirconia doped with yttria was not selected because of low-temperature 
degradation (LTD) concerns.  Bartolomé et al [25] noted that alumina-zirconia composites 
are “promising candidates for biomedical applications, for example, total joint 
replacement...”.   
The pre-final firing ceramic blanks were produced and prepared in the laboratory and then 
machined in the Black Engineering Machine Shop by the resident machinist.  Metal parts 
were simply machined; however, features that held ceramic parts were not machined until 
final fired dimensions of the ceramic were measured.  This was done to ensure that the 
ceramic component would fit into metal opening after shrinking to final dimensions.   
Humeral Component 
The humeral component can be more easily thought of as a ball and pin assembly.  It has 
eight parts that work to hold a ZTA ball along the center of rotation of the humerus.  The ball 
is designed to articulate with both the radius and ulna components and is held in place by two 
stainless steel nuts on a threaded stainless steel rod.  Two sides of the ball are machined flat 
and parallel to ensure a tight fit by the nuts.  One of the nuts has a thin tube extension out 
from its inner diameter to provide a smooth surface for the ball to rest on.  The other nut 
screws onto the end of this thin tube to hold the ball in place.  This ball and nut assembly can 
be rotated to easily move to a desired position on the threaded rod. 
The threaded rod is secured to the humerus with two end caps.  The end caps ride on the 
threaded shaft and have three small spikes to set it into the cancellous bone of the humerus.  
One of the end caps is threaded and is screwed into place against the humerus while the other 
is not threaded and is simply forced against the humerus.  Each end cap also has an 
osteoceramic cylinder as in interface to improve fixation with bone bonding.  The 
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osteoceramic has longitudinal grooves to prevent rotation and increase surface area for bone 
attachment.  It is press-fitted inside the humerus when the end caps are set in place.  
 
Figure 26: Humeral component assembled and disassembled into parts. 
Radial Component 
The radial component has five parts and transfers load from the ball of the humeral 
component to the radius.  A cylinder of ZTA with a concave depression rests against the 
humeral ball and articulates smoothly against it.  The cylinder is set into a stainless steel cup 
which has a cylindrical extension with internal threads.  These threads allow the cup to be 
threaded onto a stainless steel base.  A perfect fit against the humeral ball and ZTA cylinder 
is achieved by adjusting along this base.  The base is secured against the radius with a bone 
screw and, like the humeral end caps, holds a cylinder of osteoceramic for bone attachment 
and long term stability.  
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Figure 27: Radial component. 
Ulnar Component 
The ulnar component provides additional stability to the implant and supports some of the 
load from the humeral component.  It has two parts, a ZTA surface to articulate with the 
humeral ball and a stainless steel “boat” that affixes it to the ulna.  The “boat” has a long keel 
with two transverse holes drilled in it and a ridge to help it remain attached to the GCOC-
cement that holds the component in place.  The back of the keel is slightly tapered so it is 
more difficult to remove once it is set in place. The sides of the “boat” have curved flanges to 
follow the curvature of the cut in the ulna and to hold cement.  There is a hole in the front of 
the “boat” which is designed to hold a standard bone screw.  This bone screw will be angled 
toward the olecranon and will provide additional stabilization, especially until the cement has 
fully set. 
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Figure 28: Ulnar component side and front views. 
Cadaver Canine Joint Examination 
Dr. William Hoefle, DVM, MS; an orthopaedic surgeon at the Iowa State University College 
of Veterinary Medicine and the Lloyd Veterinary Medical Center was consulted to determine 
the viability of the constructed elbow implant.  He was initially optimistic, but was concerned 
that after removal of the trochlea, the lateral condyle may not have sufficient support from 
ball and pin assembly to prevent fracture.  The proposed surgical procedure, which would 
approach the elbow joint cranially instead of caudally, was also discussed.  He felt that the 
presence of nerves, veins/arteries, and muscle tissue on the cranial side would make such a 
procedure difficult, but he was willing to investigate the possibility on a cadaver canine 
elbow. 
The cranial approach on the cadaver was successful; however a significant amount of muscle 
tissue was separated and the exposure provided was not large enough for the designed cutting 
apparatus.  Widening the exposure would increase the possibility of damage to the radial 
nerve.  Dr. Hoefle suggested an alternative approach, similar to one used commonly in 
surgical practice, where the joint is approached caudally and an osteotomy is done in the 
proximal ulna just below the elbow joint.  This allows easy access to all of the elbow joint 
and afterwards the proximal ulna is reattached with a pin and a figure-eight of tension band 
wire. 
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While examining the articulation of the humerus and radius (with the proximal ulna 
displaced), Dr. Hoefle expressed concern that the radius would articulate too far laterally on 
the humerus.  This might require that more of the lateral condyle be removed, further 
weakening boney support.  He did not say it was impossible, but did suggest that some 
alterations of the implant might alleviate this potential problem. 
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SUMMARY AND CONCLUSIONS 
The ball-centered elbow joint replacement prototype design called for a strong metal 
backbone with wear resistant articulating surfaces.  Bone bonding at the implant-tissue 
interface was also desired.  Stainless steel, ZTA, and osteoceramic were selected to meet 
these criteria.  The designed parts were manufactured and assembled into a working 
prototype.   
ZTA can be relatively easily produced and sintered into a dense ceramic with high fracture 
toughness, good tensile strength, excellent wear resistance, and almost no negative impact to 
other material properties.  When alumina is prepared by CeramTec for their Biolox® 
products (most prevalent total hip replacement ceramic), a hot isostatic pressing operation is 
required [33,34].  It appears that the powder-alkoxide mixing and open air sintering method 
used in this research to create a nanocomposite ZTA is a viable alternative to the costly hot 
isostatic pressing process currently implemented by CeramTec. 
Many compromises had to be made to create the ball-centered elbow joint replacement 
prototype detailed in this research.  The original design was envisioned for humans and many 
changes had to be made to adapt the (now current) design to a canine elbow.  After reviewing 
a cadaver canine elbow joint, another change may be required.  The location of the ZTA ball 
needs to move laterally, which may require envisioning a new humeral component instead of 
the ball and pin assembly.  This may be advantageous, because there is some concern that the 
3/32” pin would not be strong enough to for long term use.   
The ultimate goal is to create an elbow replacement for use in humans.  The current ball and 
pin design for the humerus may still be viable for this application; however, it is likely that 
two balls would be necessary because humans have more forearm rotation than canines.  A 
human elbow is significantly larger than a canine’s so it is possible that some of the current 
concerns could be resolved simply because there is more space and bone stock.  The entire 
implant could easily be upscaled which would should alleviate concerns about the size of the 
pin. 
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It is strongly believed that the use of osteoceramic and CGOC-cement will significantly 
decrease the likelihood of aseptic loosening.  Bone will bond to the osteoceramic to create a 
stronger bone-implant interface than is currently seen in implants that use PMMA bone 
cement.  CGOC-cement can provide similar strength to PMMA bone cement and, like its 
precursor OC-cement, does not increase in temperature enough to cause tissue necrosis.  
Neither osteoceramic nor CGOC-cement will cause a negative foreign body response if wear 
or fracture particles are released, a huge advantage over PMMA bone cement. 
It is recommended that the implant be tested in a cadaver canine as soon as a humeral 
component alternative is designed.  The short- and long-term strength of the bone-
osteoceramic interface needs to be investigated to determine if more or less osteoceramic is 
required to achieve adequate strength.  After a successful cadaver experiment, an in vivo 
study should be performed.  Before implantation in vivo, ZTA components will need to be 
polished against each other to ensure a matched, smooth surface to provide maximum wear 
resistance.  
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APPENDIX I:  ALUMINA 
Table 9: Properties of single-crystal α-Al2O3. [32] 
Melting point (°C) - 2051 ± 9.7 
Density (g/cm
3
) - 3.98 
Refractive index 
ordinary ray (c-axis) 1.768 
extraordinary ray 1.760 
Hardness (GPa) HV500g 
parallel to c 19.03 
perpendicular to c 21.56 
Young's modulus (GPa) 
parallel to c 
at RT 435 
1000C 386 
RT compressive strength 
(GPa) - 2 
Bend Strength (MPa) 
along c-axis at RT 1035 
perpendicular to c-axis at RT 760 
at 45d to c at 600°C 325 
at 45d to c at 1000°C 587 
Thermal expansion 
coefficient (10
-6
/K) 
0-127°C 6.26 (ll c) 5.51 (perp. c) 
0-527°C 7.96 7.15 
0-1127°C 8.84 7.96 
0-1727°C 9.18 8.30 
Thermal conductivity 
(W/m*K) 
RT 36 
100°C 28.9 
500°C 10.5 
1100°C 5.9 
1900°C 6.3 
 
Table 10: Properties of Ceralox APA-0.5 alumina. [35] 
Product Al2O3 Purity D-90 µm D-50 µm D-10 µm Surface Area, m
2
/g 
APA-0.5 99.96% 0.5 0.3 0.2 8.0 
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APPENDIX II:  ZIRCONIA-TOUGHENED ALUMINA SYNTHESIS 
Note: The following was developed following the procedure given by Schehl et al [26]. 
1. Pour ~400mL of 200 proof ethanol into a 1000mL beaker. Insert a 3 inch magnetic 
stirring rod and place the beaker on a hot/stirring plate set to stirring level 8 or 9 (heat 
off for now). 
2. Carefully add 190.00g of Ceralox APA-0.5 alumina (no MgO) (see APPENDIX I) 
into the beaker and disperse the powder in the ethanol. Add more ethanol and/or 
adjust stirring speed as necessary to keep the powder dispersed. 
3. Pour ~40mL of Sigma-Aldrich zirconium(IV) propoxide solution (70wt.% in 1-
propanol) into a 50mL beaker. Use a 10mL graduated cylinder to transfer 36.2mL 
into a 100mL mix beaker. 
4. Measure out ~18mL of 200 proof ethanol in the same 10mL graduated cylinder. Pour 
into the 100mL mix beaker with zirconium solution. Gently swirl beaker. 
5. Pour or use a disposable pipette to transfer the zirconium/ethanol solution from the 
mix beaker to the 1000mL beaker containing ethanol/alumina slurry. Add the solution 
slowly—do not spill or splash solution out of the beaker. Pour any remaining solution 
into the 1000mL beaker if it cannot be reached with the pipette.  
6. Turn on the hot plate to level 5 and check that the stirring speed is sufficient.  
7. As the ethanol evaporates residue will be left on the wall of the beaker.  Use a rubber 
spatula to scrape this residue back into the slurry or rinse the walls of the beaker with 
ethanol.  If a rubber spatula is used, rinse it with ethanol to make sure any residue on 
the spatula goes back into the beaker.  Once all of the ethanol has evaporated or the 
magnetic stirring rod no longer spins (this should take 4-6 hours), remove the 
magnetic stirring rod and scrape any powder/slurry back into the beaker.  It is OK if 
the slurry is not completely dry. 
8. Cover the beaker with a watchglass and set it in the large oven at ~120°C overnight to 
remove any traces of ethanol. 
9. Break up the white chunks in the bottom of the beaker and transfer the 
powder/chunks into a 500mL wide mouth plastic jar.  Add ¼” cylindrical alumina 
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grinding media until the jar is about 2/3 full and then run it in the vibration mill for 4 
hours.  Sift the powder through a 40 mesh sieve.   
10. Place the milled powder in an alumina crucible and cover it with a platinum foil 
square.  Set the crucible in a furnace and calcine at 850°C.  Store. 
Thermal Treatment of Powder at 850°C 
1. Ramp to 500°C at 100°C/hour 
2. Dwell 2 hours 
3. Ramp to 850°C at 200°C/hour 
4. Dwell 2 hours 
5. Ramp to 20°C at 100°C/hour 
6. End 
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APPENDIX III:  OSTEOCERAMIC SYNTHESIS  
Material Description/Manufacturer Amount 
Spinel S30CR Spinel, Baikowski 313.03 g 
Ca3(PO4)2 Mallinckrodt, Rhodia- TCP 277.19 g 
PEG 600 Carbowax Sentry 17.90 g 
Darvan Na Darvan #7, Vanderbilt 26.60 g 
DI H2O De-Ionized Water 520 mL 
Place the above materials into a one gallon ball mill jar, adding DI H2O first, then Darvan 
and PEG 600, followed by the dry materials. Use ¾” cylindrical alumina grinding media and 
mill for 12-18 hours. Remove slurry from the mill and dry on a plaster slab, making sure you 
place cheesecloth on the plaster slab before placing the OC on it. 
After 2-3 days, remove the OC from the plaster slab and dry it in a drying oven overnight.  
Grind the dry OC to -80 mesh with a mortar and pestle. 
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APPENDIX IV:  COLD ISOSTATIC PRESSING SPECIMEN 
PREPARATION 
Remember: It is best to have the powders as tightly packed as possible before isostatic 
pressing.  This will help you get a sample closer to the size of the mold, and increase the 
chances of a successful (high green density) press. 
 
1. Cap one end of an oil-resistant rubber tube (approximately 6 in. long) of desired 
diameter with a rubber stopper. Be sure that there are no holes in the stopper or 
rubber tube. Clamp the tube onto the stopper with a hose clamp. 
2. Place the rubber tube into a plastic sleeve of appropriate size. The sleeve will help 
keep the sample a consistent shape and diameter. 
3. To pack the sample, place some powder into the tube and use a steel rod to tamp the 
powders until densely packed. Repeat until the tube is filled. Be sure to leave room 
for a stopper at the end of the tube. 
4. Remove the plastic sleeve from the sample and cap the end of the tube with a second 
rubber stopper and clamp.  Take care to prevent trapping air inside the tube. 
5. Make sure that your sample is air tight so that no oil contaminates the sample and no 
powder gets into the oil.  The specimen is now ready for cold isostatic pressing. 
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APPENDIX V:  FIRING PROGRAMS 
1200°C Osteoceramic Firing Program: 
1. Ramp up to 1200°C at 100°C/hr 
2. Dwell at 1200°C for 2 hours 
3. Ramp down to 20°C at 100°C/hr 
4. End 
 
1450°C Osteoceramic Firing Program: 
1. Ramp up to 1450°C at 100°C/hr 
2. Dwell at 1450°C for 2 hours 
3. Ramp down to 20°C at 100°C/hr 
4. End 
 
1000°C ZTA Firing Program: 
1. Ramp up to 1000°C at 100°C/hr 
2. Dwell at 1000°C for 30 minutes 
3. Ramp down to 20°C at 100°C/hr 
4. End 
 
1650°C ZTA Firing program: 
1. Ramp up to 1600°C at 100°C/hr 
2. Ramp up to 1650°C at 60°C/hr 
3. Dwell at 1650°C for 15 minutes 
4. Ramp down to 20°C at 100°C/hr 
5. End 
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APPENDIX VI:  IMPLANT AND SURGICAL INSTRUMENTS DESIGN  
The following section was written by Dr. Thomas McGee: 
Recent improvements in laparoscopic repair of synovial joints, minimized access incisions, 
and robotic surgical tools have improved surgical performance, reduced pain, and improved 
recovery.  However, joint replacements have not change much since Charley first used 
PMMA cement and polyethylene in 1948.  Many attempts to replace the articulating 
components have failed because bone does not bond to the metals, plastics, and ceramics that 
are still in use. 
The osteoceramic elbow joint design is revolutionary in nature because it does not remove 
the function nature of the lower (distal) end of the humerus.  That bone is one of the densest 
in the skeleton.  By preserving it, much less trauma occurs.  The anterior approach to the 
articulating components makes it possible to replace just the articulating components.  It is 
revolutionary also because bone will bond to the osteoceramic component and cause the 
implant to be anchored firmly in the bone. 
Replacing conventional polyethylene (PE) wear components prevents failure due to PE 
particles in the synovial cavity that cause inflammatory response, pain, and loosening. 
The new design is controversial because of the difficulty in surgical performance without 
damage to muscles, tendons, and nerves.  The surgical procedure requires removal of a 
section of the trochlea (humerus bearing surface) and replacing it with a ZTA ball at the 
center of rotation for the joint, and also at, or near, the center of rotation of the radius.  This 
may not be possible but must be evaluated experimentally. 
If this approach is practical, special surgical instruments are needed to maintain the stability 
of the centers of rotation during the procedure.  These have been designed and manufactured.  
They will be used in a simulated surgery using a cadaver foreleg in the near future.  An 
alternative approach suggested by Dr. Hoefle will also be evaluated.  
59 
 
APPENDIX VII:  ELBOW IMPLANT SCHEMATICS 
The following pages show the specific dimensions of each part of the elbow joint 
replacement prototype.  Gray parts are stainless steel, teal parts are ZTA, and gold parts are 
osteoceramic.  NF threads refers to the standard national fine thread size and all dimensions 
are in inches.  Fully sintered dimensions are given for the ceramic components.  The 
dimensions given to the machinist can be determined by increasing the listed dimensions by 
17.8% for osteoceramic and 21.6% for ZTA. 
Figures 29-34: Humeral component parts 
Figures 35-38: Radial component parts 
Figures 39-40: Ulnar component parts  
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Figure 29: Threaded rod for humeral component. 
 
Figure 30: Ball core tube for humeral component. 
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Figure 31: Nut for humeral component. 
 
Figure 32:  End cap for humeral component. 
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Figure 33: ZTA ball for humeral component. 
 
Figure 34: Osteoceramic sleeve for humeral end caps. 
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Figure 35: Metal cup for radial component. 
 
Figure 36: Metal base for radial component. 
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Figure 37: ZTA articulating surface for radial component. 
 
Figure 38: Osteoceramic sleeve for radial component 
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Figure 39: Metal "boat" for ulnar component. 
 
Figure 40: ZTA articulating surface for ulnar component. 
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